Cancertope

In silico Platform for designing genome-based
Personalized immunotherapy or Vaccine against Cancer

Predicted Immune Epitope Results


The result page of search shows exclusive peptide/epitopes generated due to mutation [Neoepitope], the tissue of origin [Tissue], position of peptide in protein [Position], number of mismatches counted by aligning mutated and normal protein sequence [Num Mismatch, percentage of cell lines with this peptide over total number of cell lines [Promiscuity %]. The immune information include CTL epitopes (Yes/No), MHC I binders, MHC II binders (both given as number of alleles) and B cell epitopes (Yes/No). For more information, please click HERE


NeoepitopesVLIVEYLQI        Click here to BLAST against human proteome
CTL Epitope
(CTLPred)
N
HLA I Alleles
(ProPred I)
HLA-A*0201, HLA-A*0205, HLA-A2, HLA-A2.1, HLA-A3, HLA-B*51, HLA-B*5101, HLA-B*5102, HLA-B*5301, HLA-B62, HLA-Cw*0301, MHC-Db, MHC-Kb, MHC-Kd, MHC-Kk15
HLA I Alleles
(nHLAPred)
NA0
HLA II Alleles
(PrePred)
DRB1_0101, DRB1_0102, DRB1_0701, DRB1_0703, DRB1_1101, DRB1_1104, DRB1_1106, DRB1_1128, DRB1_1305, DRB1_1311, DRB1_1501, DRB1_1502, DRB1_1506, DRB5_0101, DRB5_010515
B_Cell_Epitope
(ABCPred)
Y

CANCERTOPE    |     Raghava's Group    |     IMTECH    |     CSIR    |     CRDD    |     GPSR Package